home / stock / cadl / cadl message board
Subject | By | Source | When |
---|---|---|---|
$CADL here we go bulls news is here | MiamiGent | investorshub | 04/25/2023 7:34:02 PM |
where is the squeeze? | subslover | investorshub | 04/25/2023 7:07:26 AM |
$CADL got some short data | MiamiGent | investorshub | 04/23/2023 9:01:49 AM |
where is the squeeze? | subslover | investorshub | 04/17/2023 10:33:11 AM |
$CADL Looks pretty positive | axelvento | investorshub | 04/04/2023 11:28:03 AM |
Candel Therapeutics Reports Third Quarter 2022 Financial Results | axelvento | investorshub | 11/10/2022 1:33:25 PM |
Hey axe, thank you for the beautiful info. | subslover | investorshub | 11/07/2022 11:19:52 PM |
November and December news in release!!!! | axelvento | investorshub | 11/07/2022 3:32:18 PM |
Candel Therapeutics Announces Upcoming Clinical Data Presentations at | subslover | investorshub | 11/07/2022 2:21:28 PM |
Candel Therapeutics Completes Enrollment in Phase 3 Clinical | axelvento | investorshub | 10/28/2022 4:56:04 AM |
Good info, axel! | MiamiGent | investorshub | 10/27/2022 7:59:44 PM |
this is very interesting: https://www.healthleadersmedia.com/pharma/just-two-ye | axelvento | investorshub | 10/27/2022 1:27:00 PM |
GL with Candel axel! | MiamiGent | investorshub | 10/27/2022 12:32:14 PM |
Key Upcoming Milestones big | axelvento | investorshub | 10/27/2022 5:32:47 AM |
CADL is the #1 performing stock in the | MiamiGent | investorshub | 10/21/2022 2:28:22 PM |
Candel Therapeutics, Inc, formerly Advantagene, Inc, is a | crudeoil24 | investorshub | 09/22/2021 7:06:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Candel Therapeutics Inc. Company Name:
CADL Stock Symbol:
NASDAQ Market:
2024-05-16 18:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
U.S. stocks were higher, with the Dow Jones gaining around 150 points on Wednesday. Shares of Nextracker Inc. (NASDAQ:NXT) rose sharply during Wedn...
Announced positive survival data from ongoing randomized phase 2 clinical trial of CAN-2409 in borderline resectable pancreatic cancer Phase 2 topline overall survival data for CAN-2409 in non-small cell lung cancer (NSCLC), to be presented at ASCO on June 3, 2024 On track for top...